首页> 外文期刊>Paediatrics and international child health >Phenotypic characteristics and clinical manifestations of inflammatory bowel disease in infants and children under 2 years of age in Liaoning Province, China: five of six infants with IL-10R mutations
【24h】

Phenotypic characteristics and clinical manifestations of inflammatory bowel disease in infants and children under 2 years of age in Liaoning Province, China: five of six infants with IL-10R mutations

机译:辽宁省2岁以下婴幼儿炎性肠病的表型特征及临床表现:六个患有IL-10R突变的婴儿五个

获取原文
获取原文并翻译 | 示例
           

摘要

A retrospective analysis of the phenotypic characteristics, clinical manifestations, investigations and interleukin-10 receptor (IL-10R) status of inflammatory bowel disease (IBD) in infants and children under 2 years of age in Liaoning Province, China between January 2015 and October 2016 is described. Six patients without a family history of IBD were diagnosed with Crohn disease, and IL-10R mutations were detected in five of them. Compound heterozygous patients with IL-10R mutations had severe clinical manifestations, were resistant to standard medication for IBD and had a poor prognosis as haematopoietic stem cell transplantation (HSCT) was not undertaken. Two of these patients died of suspected septicaemia. IBD in infants and children under 2 years of age is life-threatening when patients with IL-10R mutations do not receive allogeneic HSCT.
机译:2015年1月至2016年1月至2016年1月至10月期间,中国兴龄儿和儿童炎症肠病(IBD)表型特征,临床表现,调查和白细胞介素-10受体(IL-10R)地位的回顾性分析 描述了。 没有IBD家族历史的六名患者被诊断出患有Crohn疾病,并且在其中5个中检测到IL-10R突变。 复方杂合患者患有IL-10R突变的临床表现严重,对IBD的标准药物有抗性,并且预后差是未进行血包膜细胞移植(HSCT)。 其中两名患者死于疑似败血症。 当IL-10R突变患者不接受同种异体HSCT时,2岁以下婴儿和2岁以下的儿童危及生命。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号